Article info

Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

Authors

  1. Correspondence to Professor Yuichiro Ogura, Department of Ophthalmology & Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan; ogura{at}med.nagoya-cu.ac.jp
View Full Text

Citation

Ogura Y, Jaffe GJ, Cheung CMG, et al
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

Publication history

  • Received February 19, 2021
  • Accepted June 28, 2021
  • First published July 22, 2021.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.